CRYOUS
Closed
Back To Top
Last Updated: Dec 4, 2019 3:38 p.m. EST Delayed quote

$0.33

0.00 0.00%
Health Care/Life Sciences 0.38%
Previous Close
$0.33
Advanced Charting
  • $
  • %
  • Vol
Advanced Charting
79.07% vs Avg.
Volume: 18.7K 65 Day Avg. - 23.7K
Open: 0.33
Close: 0.33
0.27 Day Low/High 0.33
Day Range
0.1752 52 Week Low/High 0.642

Your Watchlist

Customize MarketWatch

Have Watchlists? Log in to see them here or sign up to get started.

Symbol
Company
Price
Chg/Chg %
No Items in Watchlist

There are currently no items in this Watchlist.

No Saved Watchlists

Create a list of the investments you want to track.

Uh oh

Something went wrong while loading Watchlist.

Recently Viewed Tickers

No Recent Tickers

Visit a quote page and your recently viewed tickers will be displayed here.

Key Data

  • Open $0.33
  • Day Range 0.27 - 0.33
  • 52 Week Range 0.1752 - 0.642
  • Market Cap $16.28M
  • Shares Outstanding 49.23M
  • Public Float 25.18M
  • Beta n/a
  • Rev. per Employee $84.94K
  • P/E Ratio n/a
  • EPS $-0.03
  • Yield n/a
  • Dividend n/a
  • Ex-Dividend Date n/a
  • Short Interest n/a
  • % of Float Shorted n/a
  • Average Volume 23.68K

Performance

5 Day
  • -13.16%
1 Month
  • 0.00%
3 Month
  • 82.22%
YTD
  • -44.07%
1 Year
  • -25.00%

Recent News

  • MarketWatch
  • WSJ

No Headlines Available

No Headlines Available

Recent News

  • Other News
  • Press Releases

10-Q: AMERICAN CRYOSTEM CORP

on Edgar Online - (EDG = 10Q, 10K)

10-Q: AMERICAN CRYOSTEM CORP

on Edgar Online - (EDG = 10Q, 10K)

10-Q: AMERICAN CRYOSTEM CORP

on Edgar Online - (EDG = 10Q, 10K)

10-K: AMERICAN CRYOSTEM CORP

on Edgar Online - (EDG = 10Q, 10K)

No Headlines Available

American Cryostem Corp.

American CryoStem Corp. is engaged in the development, market, and licenses patented adipose tissue-based cellular technologies, bio-materials, and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and adipose-derived stem cells; and also provides contract manufacturing services to physicians and other medical professionals that perform tissue transfer and other cellular therapy services, as well as offers professional services, including sterility, viability, cellular density, and growth assay analysis. The company was founded by Anthony Francis Dudzinski on November 18, 2008 and is headquartered in Eatontown, NJ. (See Full Profile)

Competitors

Name Chg % Market Cap
Brainstorm Cell Therapeutics Inc. 0.00% $90.2M
Verastem Inc. -3.52% $101.86M
Caladrius Biosciences Inc. 0.59% $26.52M
Arrowhead Pharmaceuticals Corp. -3.20% $6.36B
Fate Therapeutics Inc. 0.64% $1.07B
Competitor Data Provided ByCapital Cube Logo